0
Anatara Lifesciences Limited Banner Image

Anatara Lifesciences Limited

  • Ticker ANR
    Exchange ASX More
  • Industry Biotechnology More
  • Sector Healthcare More
Anatara Lifesciences Limited Logo Image
  • 1-10 Employees
  • Based in Carlton, Australia
Anatara Lifesciences Limited engages in the research and development of evidence based solutions for gastrointestinal diseases in animals and humans in Australia. It offers Gastrointestinal ReProgramming (GaRP), a proprietary formulation that combines bromelain with other evidence-based ingredients to address the primary underlying factors associated with human gastrointestinal conditionsMore, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD); and 3FDC for the treatment of anxiety, stress, or depression. The company also provides Detach for the treatment of diarrhea disease in piglets. In addition, it is developing bromelain-based formulations for piglets and poultry. Anatara Lifesciences Limited was incorporated in 2010 and is based in Carlton, Australia.
Anatara Lifesciences Limited

Most Recent Annual Report

Anatara Lifesciences Limited
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports